Research peptide · Neuropeptide research
P021
Also known as P21 · Ac-DGGL(adamantylglycine)-NH2
A small adamantane-modified peptide derived from a ciliary neurotrophic factor sequence, capped at both ends. Molecular formula C27H42N6O8, average molecular weight 578.66 g/mol.
- Compound type
- Research peptide
- Research area
- Neuropeptide
- Formula
- C27H42N6O8
- Average mass
- 578.658 Da
- Monoisotopic mass
- 578.3064 Da
- PubChem
- CID 56599151
What it is
P021 is a synthetic peptidomimetic built on a four-residue core, Asp-Gly-Gly-Leu, taken from a sequence of ciliary neurotrophic factor, with an adamantylglycine residue added at the C terminus. The N terminus is acetylated and the C terminus is a primary amide, which is reflected in the PubChem title for CID 56599151, Ac-dggl-adamatanylglycine-NH2.
Its molecular formula is C27H42N6O8, its average molecular weight is 578.66 g/mol and its monoisotopic mass is 578.31. The compound also appears in the literature under the shorter designation P21.
Structure and chemistry
The adamantyl group is the structural feature that sets this molecule apart from an ordinary short peptide. Adamantane is a rigid, highly lipophilic tricyclic hydrocarbon, and attaching it to a small, otherwise polar peptide raises lipophilicity sharply while adding bulk that resists proteolysis.
With both termini capped, the only ionizable group left is the aspartate side chain, so the molecule carries a single negative charge at neutral pH. There is no aromatic residue, so ultraviolet absorbance above 220 nm is negligible and chromatographic detection is at low wavelength or by mass spectrometry. The Asp-Gly motif at the start of the sequence is the one chemists watch: aspartyl-glycine sequences are the classic site of aspartimide formation and isomerization.
How it is studied in the laboratory
The published work is mouse work from one group, using the 3xTg transgenic model of Alzheimer-type pathology. A 2014 study gave the compound to transgenic and wild-type female mice over twelve months and measured tau phosphorylation and amyloid-beta levels by immunohistochemistry and Western blot, alongside markers of neurogenesis and synaptic plasticity and standard behavior assays; the authors reported reduced tau phosphorylation at several sites and reduced soluble amyloid-beta in the mice receiving the compound 1.
A 2017 study from the same laboratory started the compound earlier in the life of the same mouse model and followed animals at 9, 15 and 18 months, using Fluoro-Jade C staining for neurodegeneration together with immunohistochemistry and Western blots for the same pathology markers 2. The research area is neurodegeneration modeling in transgenic mice, and no independent replication outside this group was located.
Analytical notes
Identity is confirmed by liquid chromatography coupled to mass spectrometry in positive ion mode, with the expected singly protonated ion near m/z 579.31. The adamantyl group gives a characteristic fragmentation signature in tandem mass spectrometry, which is useful because the sequence is otherwise short and uninformative.
Purity is assessed by reversed-phase HPLC. The lipophilic adamantyl group gives strong retention on C18 despite the small size of the molecule, which separates it well from polar synthetic impurities. The peaks worth resolving are the aspartimide and isoaspartyl rearrangement products, the free acid from incomplete amidation and the uncapped intermediate.
Storage and handling in the laboratory
As supplied, the material is a lyophilized powder, stored at -20 degrees Celsius, sealed and protected from light and moisture. Because the adamantyl group lowers aqueous solubility, an organic co-solvent is often needed for stock solutions, and the aspartyl-glycine motif argues for avoiding alkaline buffers in anything held in solution for long.
Open questions in the literature
No molecular target has been identified for this compound: it is described by reference to the neurotrophic factor its core sequence derives from, not by a measured binding interaction. The published work is confined to one transgenic mouse model and one group, and there are no published physicochemical data on solubility or solution stability.
Identity check
A mass-spectrometry result for P21 should show peaks near these values. A result more than about one unit away is worth a question to the testing lab. Salt forms such as acetate or TFA do not move these peaks, though they do mean less peptide in each milligram of powder.
| Ion | Expected m/z |
|---|---|
| [M+H]+ | 579.31 |
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.
